Company / SG&A per Share
Avidity Biosciences, Inc. SG&A per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.49
FY2025
5-year range
$0.63 / $1.49
FY2021-FY2025
Trend
+93.1%
vs FY2024
Sector context
#98 of 210
Health Care
What the data says
At $1.49, Avidity Biosciences, Inc.'s sg&a per share ranks #113 of 210 in the Health Care sector. SG&A per Share has increased for 5 consecutive years, from $0.62 in FY2020 to $1.49 in FY2025.
Based on SEC 10-K filings.
1.49 in FY2025 with a 5-year CAGR of +19.2%.
Increased from $0.74 to $1.49 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +27.3%
- 5-Year CAGR
- +19.2%
- 10-Year CAGR
- -
Sector benchmark
#113 of 210 in Health CareTop 53% of 210This company $1.49 Sector average $40.75
▼
-96.3% below sector average
Key checks
Key Insights
- Avidity Biosciences, Inc.'s sg&a per share has grown for 5 consecutive years.
- In FY2025, sg&a per share increased 93.1% year-over-year.
- Ranks #98 out of 210 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.49 | +93.1% |
| FY2024 | $0.77 | +4.1% |
| FY2023 | $0.74 | +2.6% |
| FY2022 | $0.72 | +14.4% |
| FY2021 | $0.63 | +1.7% |
| FY2020 | $0.62 | -67.0% |
| FY2019 | $1.88 | +91.2% |
| FY2018 | $0.99 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026